Interferon-α2b/ribavirin (REBETRON®) treatment for chronic hepatitis C -: Population pharmacokinetics and pharmacodynamics of ribavirin.

被引：0
|
作者：
Glue, P [1 ]
Jen, F [1 ]
Gupta, SK [1 ]
Lau, G [1 ]
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
119
引用
收藏
页码：190A / 190A
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Gross, JB
    HEPATOLOGY, 2000, 31 (03) : 807 - 807
  • [42] Clinical comparison of high-dose interferon-α2b with or without ribavirin for treatment of interferon-relapsed chronic hepatitis C
    Cheng, PN
    Chow, NH
    Hu, SC
    Young, KC
    Chen, CY
    Jen, CM
    Chang, TT
    DIGESTIVE AND LIVER DISEASE, 2002, 34 (12) : 851 - 856
  • [43] Successful treatment of giant cell hepatitis with rebetron (interferon/ribavirin)
    Liu, JJ
    Piper, JK
    Glickman, JN
    Farraye, FA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (01): : 223 - 224
  • [44] Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α
    Tromm, A
    Greving, I
    Hueppe, D
    GASTROENTEROLOGY, 1999, 116 (04) : A834 - A834
  • [45] Triple combination treatment of chronic hepatitis C is effective in nonresponders to interferon plus ribavirin.
    Stauber, RE
    Hegenbarth, KS
    Hackl, F
    Hofer, H
    Munda-Steindl, P
    Ferenci, P
    HEPATOLOGY, 2000, 32 (04) : 558A - 558A
  • [46] Efficacy and safety of pegylated interferon-α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Santin, M
    Shaw, E
    Garcia, MJ
    Delejido, A
    De Castro, ER
    Rota, R
    Altés, J
    Baguena, F
    Valero, S
    Sala, M
    Casanova, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (04) : 315 - 320
  • [47] A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C
    Dieperink, E
    Ho, SB
    Thuras, P
    Willenbring, ML
    PSYCHOSOMATICS, 2003, 44 (02) : 104 - 112
  • [48] Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation:: A randomized study
    Samuel, D
    Bizollon, T
    Feray, C
    Roche, B
    Ahmed, SNS
    Lemonnier, C
    Cohard, M
    Reynes, M
    Chevallier, M
    Ducerf, C
    Baulieux, J
    Geffner, M
    Albrecht, JK
    Bismuth, H
    Trepo, C
    GASTROENTEROLOGY, 2003, 124 (03) : 642 - 650
  • [49] Efficacy of human recombinant interleukin 10 (IL-10) prior to re-treatment with interferon α-2b and ribavirin in chronic hepatitis C patients who failed to respond to a previous course of interferon α-2b and ribavirin.
    Sponseller, CA
    Goudey, KL
    Brass, CA
    Bacon, BR
    HEPATOLOGY, 2001, 34 (04) : 578A - 578A
  • [50] Pegylated interferon alpha 2b (PEG IFN) plus ribavirin (R) for treatment of chronic hepatitis C: Optimization of ribavirin dose
    Manns, M
    Mc Hutchison, JG
    Gordorn, S
    Rustgi, V
    Lee, MV
    Ling, ML
    Cohard, M
    Albrecht, JK
    JOURNAL OF HEPATOLOGY, 2001, 34 : 236 - 236
12345